As hospitals give more and more COVID-19 patients albuterol to help them breathe, people with asthma may have a hard time getting an inhaler. The American College of Allergy, Asthma and Immunology (ACAAI) said some areas of the United States are experiencing shortages of albuterol inhalers, and the shortage may spread. But Dr. Michael Blaiss, executive medical director of the ACAAI, emphasized that it is “nothing to panic about.” Manufacturers are trying to keep up with the unexpected surge in demand, he said. Production issues are not to blame. “No one should panic or hoard albuterol, though since you need a prescription, it’s not possible to hoard like toilet paper. But don’t put your albuterol asthma inhalers on autofill. If your asthma is under optimal control, an inhaler should last you more than a year,” Blaiss said. And, if you can’t get an albuterol inhaler from your pharmacy, Blaiss said it’s important to know there are other options. Patients with COVID-19 infections were initially treated with nebulizers, a common way to treat breathing problems in hospitals, and sometimes at home. But recent research suggested that when aerosolized, the coronavirus could hang in the air for a while, and some nebulizers might aerosolize the virus particles, Blaiss explained. So, out of caution, many hospitals have switched to the use of albuterol inhalers. Albuterol is a medication… read on >

















